cenegermin-bkbj
| Brand name | Oxervate |
|---|---|
| Active ingredient | cenegermin-bkbj |
| Strength | 0.002% (20MCG/ML) |
| Dosage form | Solution |
| Route | Topical |
| Modality | Biologic |
| FDA approval | August 2018 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.